CALABRESE, Cecilia
 Distribuzione geografica
Continente #
EU - Europa 3.568
NA - Nord America 2.568
AS - Asia 2.567
SA - Sud America 485
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.221
Nazione #
US - Stati Uniti d'America 2.526
RU - Federazione Russa 1.322
SG - Singapore 894
IE - Irlanda 733
CN - Cina 527
HK - Hong Kong 429
BR - Brasile 415
IT - Italia 396
UA - Ucraina 294
DE - Germania 252
GB - Regno Unito 248
KR - Corea 222
JP - Giappone 141
VN - Vietnam 125
SE - Svezia 87
FI - Finlandia 82
IN - India 67
TR - Turchia 60
GR - Grecia 55
FR - Francia 34
AR - Argentina 26
MX - Messico 17
BE - Belgio 16
AT - Austria 14
ID - Indonesia 14
CA - Canada 13
EC - Ecuador 12
IQ - Iraq 12
SC - Seychelles 12
BD - Bangladesh 11
PH - Filippine 11
CO - Colombia 10
ZA - Sudafrica 9
PK - Pakistan 8
PY - Paraguay 8
PL - Polonia 7
NL - Olanda 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
AZ - Azerbaigian 4
HN - Honduras 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
LT - Lituania 4
MA - Marocco 4
UY - Uruguay 4
PT - Portogallo 3
VE - Venezuela 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
ES - Italia 2
EU - Europa 2
IR - Iran 2
KG - Kirghizistan 2
PA - Panama 2
RO - Romania 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 9.221
Città #
Dublin 733
Moscow 479
Jacksonville 458
Hong Kong 429
Singapore 336
Santa Clara 319
Chandler 318
Seoul 216
Princeton 110
Bremen 109
Roxbury 97
Ann Arbor 88
Ashburn 86
Hefei 86
Medford 62
Cambridge 60
Wilmington 58
Beijing 51
Bengaluru 46
The Dalles 46
Boardman 41
Houston 41
Naples 40
Ho Chi Minh City 37
Dallas 33
Mountain View 32
Hanoi 31
Munich 31
Woodbridge 30
São Paulo 27
New York 26
Bari 23
Caserta 23
San Mateo 23
Jinan 21
Nuremberg 21
Rome 20
Des Moines 17
Brussels 16
Los Angeles 16
Shenyang 14
Guangzhou 13
Tianjin 13
Fuzhou 12
Marano Di Napoli 12
Rio de Janeiro 12
Belo Horizonte 10
Changsha 10
Nanjing 10
Aversa 9
Helsinki 9
Nanchang 9
Napoli 9
Quezon City 9
Vienna 9
Hangzhou 8
Ningbo 8
Quito 8
Da Nang 7
Düsseldorf 7
Frankfurt am Main 7
Istanbul 7
Jakarta 7
Milan 7
Mumbai 7
Putian 7
Tokyo 7
Boston 6
Brasília 6
Curitiba 6
Cursi 6
Salvador 6
Villaricca 6
Zhengzhou 6
Atlanta 5
Brooklyn 5
Columbus 5
Ercolano 5
Fisciano 5
Goiânia 5
Mexico City 5
Norwalk 5
Redwood City 5
San Francisco 5
São Bernardo do Campo 5
Tashkent 5
Amman 4
Baku 4
Biên Hòa 4
Cape Town 4
Casavatore 4
Chicago 4
Dongguan 4
Falkenstein 4
Fortaleza 4
Hải Dương 4
Lappeenranta 4
Nairobi 4
Palermo 4
Pozzuoli 4
Totale 5.141
Nome #
Tollerabilità del GSH inalatorio in pazienti pediatrici e adulti con fibrosi cistica 161
Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans 119
Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction 118
A CASE OF A PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA TRANSFORMED INTO AN EPITHELIOID ANGIOSARCOMA 116
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 108
ANGIOGENESIS IN BRONCHIAL BIOPSIES OF SYMPTOMATIC SMOKERS WITH AND WITHOUT LUNG CANCER 108
Exposure to Submicron Particles (PM1.0) from Diesel Exhaust and Pollen Allergens of Human Lung Epithelial Cells Induces Morphological Changes of Mitochondria Tonifilaments and Rough Endoplasmic Reticulum 106
T cell activation state in the induced sputum of asthmatics treated with budesonide 104
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages 103
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 103
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC. 102
Abdominal adiposity is an early marker of pulmonary function impairment: Findings from a Mediterranean Italian female cohort 102
[Clinical use of recombinant IFN alfa-2b in the treatment of primary cancer of the lung (preliminary results)] 101
Asma Bronchiale (recenti acquisizioni sperimentali e contributi personali) 101
ANGIOGENETIC AND APOPTOTIC PROCESS IN THE AIRWAYS OF SYMPTOMATIC SMOKERS WITH AND WITHOUT A CONTRALATERAL NON SMALL CELL LUNG CANCER 100
Immunoflogosi nell’Asma Bronchiale 99
Lung mast cells are a source of secreted phospholipases A(2). 98
Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma 98
Ruolo dei fattori di crescita nella induzione della proliferazione fibroblastica nella patogenesi della fibrosi polmonare idiopatica 98
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism 95
Basophil activation test for staphylococcus enterotoxins in severe asthmatic patients 95
Application of proteomics and peptidomics to COPD. 94
EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE 93
CORRELAZIONI TRA CELLULARITA' E MEDIATORI CHIMICI NEL LIQUIDO DI LAVAGGIO BRONCOALVEOLARE IN PAZIENTI CON ASMA BRONCHIALE ATOPICO 93
Obstructive sleep apnea and cardiovascular risks in the elderly population 93
Association between exhaled nitric oxide and nasal polyposis in severe asthma 92
A CASE OF DOUBLE AORTIC ARCH SUGGESTED BY THE ANALYSIS OF THE FLOW-VOLUME CURVE 91
BRONCHIAL VASCULARITY IN THE AIRWAYS OF CHRONIC BRONCHITIS AND COPD SMOKERS 90
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 89
ANTAGONISTI DEI LEUCOTRIENI E DI ALTRI MEDIATORI LIPIDICI 89
L'ASMA GRAVE: FENOTIPI CLINICI 87
VASCULAR REMODELLING IN BRONCHIAL MUCOSA OF SMOKERS WITH AND WITHOUT AIRWAY OBSTRUCTION 87
Dupilumab: A novel treatment for asthma 87
The serum metabolome of moderate and severe covid-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism 87
AGONISTI BETA2-ADRENERGICI 86
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers. 84
Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease. 84
Asma e gravidanza 84
CARATTERISTICHE CLINICHE E MONITORAGGIO DEI PAZIENTI AFFETTI DA ASMA BRONCHIALE GRAVE DI DIFFICILE CONTROLLO 84
NEUROPEPTIDE EXPRESSION IN THE AIRWAYS OF COPD PATIENTS AND SMOKERS WITH NORMAL LUNG FUNCTION. 83
A storm of stones in the lungs: an uncommon sequela of varicella pneumonia 83
Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy. 82
MONITORAGGIO CLINICO E IMMUNOLOGICO DI UN GRUPPO DI PAZIENTI AFFETTI DA ASMA BRONCHIALE ATOPICO O ASMA BRONCHIALE E RINITE ALLERGICA IN TRATTAMENTO IPOSENSIBILIZZANTE SPECIFICO PER VIA SOTTOCUTANEA OD ORALE 81
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE) 81
ASMA E MENOPAUSA 80
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis 80
New perspectives in asthma treatment 79
INFLUENZA DELL'INQUINAMENTO AMBIENTALE SULLA FUNZIONE RESPIRATORIA 79
NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures 78
Upregulation of miR-21 by Ras in vivo and its role in tumor growth 77
Role of monocyte/macrophage population in immune response 77
Effetti della stimolazione nasale con estratto di parietaria sui livelli di no esalato in pazienti con rinite allergica intermittente 77
Somatostatin-Dependent Regulation of Alveolar Macrophages Activation and Cytokine Production 77
ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role 77
IL POLMONE NELL'ARTRITE REUMATOIDE E NEL LUPUS ERITEMATOSO SISTEMICO 76
Correlation study of semi-quantitative CT emphysema score with the BODE index in COPD patients 76
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma 76
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis 76
Inhaled glutathione tolerability and efficacy in patients with cystic fibrosis 75
FIBROBLAST PROLIFERATION INDUCED BY GROWTH FACTORS IN DIOPATHIC PULMONARY FIBROSIS 74
FARMACI ATTIVI SUI MECCANISMI DELLA FLOGOSI 73
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma 73
S. aureus and IgE-mediated diseases: pilot or copilot? A narrative review 72
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 72
IFNg triggers apoptosis in vitro M.T. activated alveolar macrophages 72
Inhibition of Cytosolic Phospholipase A2 in Human Neutrophils by Oxatomide 71
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma 71
PHENOTYPIC FEATURES AND ACTIVATION OF ALVEOLAR MACROPHAGES IN ATOPIC ASTHMATIC PATIENTS 70
IFNY TRIGGERS APOPTOSIS IN VITRO M.T. ACTIVATED ALVEOLAR MACROPHAGES 70
EVALUATION OF THE EFFICIENCY OF CORTICOSTEROID (BECLOMETIIASONE-DIPROPRIONATE) USE IN ATOPIC PATIENTS WITH MILD ASTHMA 70
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy. 68
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 68
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 67
Risultati preliminari sull'impiego della picotamide monoidrata in pazienti asmatici 67
Diagnostica allergologica "in vivo" 66
CYTOFLUORIMETRIC ANALYSIS OF CYTOKINE-PRODUCING LYMPHOCYTES IN BAL FROM TB PATIENTS 66
CONFRONTO DEI FENOMENI DI ANGIOGENESI E DI PROLIFERAZIONE CELLULARE NELLE VIE AEREE DI FUMATORI SINTOMATICI CON E SENZA BPCO 66
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 66
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 65
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 64
Aerosol delivery through high-flow nasal therapy: Technical issues and clinical benefits 63
SCHEMI DI TERAPIA DELL'ASMA BRONCHIALE 63
Vascular remodelling in COPD airways 63
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 63
Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms 63
Inibitori delle molecole di adesione 62
Lipid mediators from mast cells and basophils in allergic diseases 62
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 62
Tiotropium Respimat Inhaler and the Risk of Death in COPD 61
Staphylococcus Aureus in chronic airway diseases: An overview 61
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients 61
Psychological Factors Influencing Adherence to NIV in Neuromuscular Patients Dependent on Non Invasive Mechanical Ventilation: Preliminary Results 60
METABOLISM OF LIPID MEDIATORS IN HUMAN EOSINOPHILS 60
Recurrent respiratory infections caused by a double aortic arch: The diagnostic role of spirometry 59
TOSSE CRONICA E MALATTIA DA REFLUSSO GASTROESOFAGEO 59
IMMUNOLOGICAL INTERACTIONS BETWEEN HUMAN EOSINOPHILS AND CARDIAC MAST CELLS 59
Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report 59
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 59
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 59
FARMACI ANTIMUSCARINICI 58
Totale 8.066
Categoria #
all - tutte 39.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021398 0 0 0 0 0 16 103 76 7 106 73 17
2021/2022769 27 1 0 5 213 46 15 32 23 117 54 236
2022/20231.428 135 9 28 107 216 113 24 59 682 14 17 24
2023/2024521 49 21 25 42 186 24 26 9 6 4 39 90
2024/20251.767 5 80 19 47 302 162 194 160 217 321 143 117
2025/20263.168 310 503 345 366 666 978 0 0 0 0 0 0
Totale 9.517